Advertisement

Signal transduction by cGMP-dependent protein kinases and their emerging roles in the regulation of cell adhesion and gene expression

  • M. Eigenthaler
  • S. M. Lohmann
  • U. Walter
  • R. B. Pilz
Chapter
Part of the Reviews of Physiology, Biochemistry and Pharmacology book series (volume 135)

Keywords

Nitric Oxide Cystic Fibrosis Transmembrane Conductance Regulator Brain Natriuretic Peptide Atrial Natriuretic Peptide Myosin Light Chain Kinase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

ANP

atrial natriuretic peptide

BHK

baby hamster kidney cells

BNP

brain natriuretic peptide

CFTR

cystic fibrosis transmembrane conductance regulator

cAMP-PK

cAMP-dependent protein kinase

cGMP-PK

cGMP-dependent protein kinase

CNP

natriuretic peptide type C

EC

endothelial cell

EDRF

endothelium-derived relaxing factor

GC

guanylyl cyclase

GnRH

gonadotropin releasing hormone

MKP-1

mitogen-activated protein kinase phosphatase

MLC

myosin light chain

MLCK

myosin light chain kinase

NLS

nuclear localization signal

NO

nitric oxide

NOS

nitric oxide synthase

HUVEC

human umbilical vein endothelial cell

8-Br-cGMP

8-bromo-cGMP

PDGF

platelet-derived growth factor

SHR

spontaneously hypertensive rats

SMC

smooth muscle cell

SNAP

S-nitrosopenicillamine

SNP

sodium nitroprusside

TGFβ1

tumor growth factor beta1

TNF

tumor necrosis factor

VASP

vasodilator-stimulated phosphoprotein

VEGF

vascular endothelial growth factor

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Angel P, Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072:129–157Google Scholar
  2. Bassenge E (1994) Coronary vasomotor responses: role of endothelium and nitrovasodilators. Cardiovasc Drugs Ther 8:601–610Google Scholar
  3. Belsham DD, Wetsel WC, Mellon PL (1996) NMDA and nitric oxide act through the cGMP signal transduction pathway to repress hypothalamic gonadotropin-releasing hormone gene expression. EMBO J 15:538–547Google Scholar
  4. Bischoff J (1997) Cell adhesion and angiogenesis. J Clin Invest 99:373–376Google Scholar
  5. Bloch W, Forsberg E, Lentini S, Brakebusch C, Martin K, Krell HW, Weidle UH, Addicks K, Fassler R (1997) Beta 1 integrin is essential for teratoma growth and angiogenesis. J Cell Biol 139:265–278Google Scholar
  6. Boerth NJ, Dey NB, Cornwell TL, Lincoln TM (1997) Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J Vasc Res 34:245–259Google Scholar
  7. Bowler C, Neuhaus G, Yamagata H, Chua NH (1994) Cyclic GMP and calcium mediate phytochrome phototransduction. Cell 77:73–81Google Scholar
  8. Brooks PC, Clark RA, Cheresh DA (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264:569–571Google Scholar
  9. Burridge K, Chrzanowska-Wodnicka M, Zhong C (1997) Focal adhesion assembly. Trends Cell Biol 7:342–347Google Scholar
  10. Butt E, Geiger J, Jarchau T, Lohmann SM, Walter U (1993) The cGMP-dependent protein kinase — gene, protein, and function. Neurochem Res 18:27–42Google Scholar
  11. Butt E, Eigenthaler M, Genieser HG (1994a) Rp-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor. Eur J Pharmacol 269:265–268Google Scholar
  12. Butt E, Abel K, Krieger M, Palm D, Hoppe V, Hoppe J, Walter U (1994b) cAMP-and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion protein VASP in vitro and in intact human platelets. J Biol Chem 269:14509–14517Google Scholar
  13. Cao L, Wu J, Gardner DG (1995) Atrial natriuretic peptide suppresses the transcription of its guanylyl cyclase-linked receptor. J Biol Chem 270:24891–24897Google Scholar
  14. Chen L, Daum G, Forough R, Clowes M, Walter U, Clowes AW (1998) Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery. Circ Res 82:862–870Google Scholar
  15. Chin K, Kurashima Y, Ogura T, Tajiri H, Yoshida S, Esumi H (1997) Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene 15:437–442Google Scholar
  16. Chu DM, Corbin JD, Grimes KA, Francis SH (1997) Activation by cyclic GMP binding causes an apparent conformational change in cGMP-dependent protein kinase. J Biol Chem 272:31922–31928Google Scholar
  17. Corbin JD, Lincoln TM (1978) Comparison of cAMP-and cGMP-dependent protein kinases. Adv Cyclic Nucleotide Res 9:159–170Google Scholar
  18. Cordelier P, Esteve JP, Bousquet C, Delesque N, O'Carroll AM, Schally AV, Vaysse N, Susini C, Buscail L (1997) Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5. Proc Natl Acad Sci USA 94:9343–9348Google Scholar
  19. Davenpeck KL, Gauthier TW, Lefer AM (1994) Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 107:1050–1058Google Scholar
  20. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MAJ, Shin WS, Liao JK (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60–68Google Scholar
  21. de Groot RP, Auwerx J, Karperien M, Staels B, Kruijer W (1991) Activation of junB by PKC and PKA signal transduction through a novel cis-acting element. Nucleic Acids Res 19:775–781Google Scholar
  22. DeJonge HR (1981) Cyclic GMP-dependent protein kinase in intestinal brushborders. Adv Cyclic Nucleotide Res 14:315–333Google Scholar
  23. Dey NB, Boerth NJ, Murphy-Ullrich JE, Chang PL, Prince CW, Lincoln TM (1998) Cyclic GMP-dependent protein kinase inhibits osteopontin and thrombospondin production in rat aortic smooth muscle cells. Circ Res 82:139–146Google Scholar
  24. Dhaunsi GS, Hassid A (1996) Atrial and C-type natriuretic peptides amplify growth factor activity in primary aortic smooth muscle cells. Cardiovasc Res 31:37–47Google Scholar
  25. Draijer R, Vaandrager AB, Nolte C, De Jonge HR, Walter U, van Hinsbergh VW (1995) Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. Circ Res 77:897–905Google Scholar
  26. Dubey RK, Jackson EK, Luscher TF (1995) Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin 1 receptors. J Clin Invest 96:141–149Google Scholar
  27. Ecker T, Gobel C, Hullin R, Rettig R, Seitz G, Hofmann F (1989) Decreased cardiac concentration of cGMP kinase in hypertensive animals. An index for cardiac vascularization? Circ Res 65:1361–1369Google Scholar
  28. Eigenthaler M, Nolte C, Halbrugge M, Walter U (1992) Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells. Eur J Biochem 205:471–481Google Scholar
  29. Eigenthaler M, Ullrich H, Geiger J, Horstrup K, Hönig-Liedl P, Wiebecke D, Walter U (1993) Defective nitrovasodilator-stimulated protein phosphorylation and calcium regulation in cGMP-dependent protein kinase deficient human platelets of chronic myelocytic leukemia. J Biol Chem 268:13526–13531Google Scholar
  30. Eigenthaler M, Shattil SJ (1996) Integrin signaling and the platelet cytoskeleton. Current Topics in Membranes 43:265–291Google Scholar
  31. Elferink JGR and de Koster BM (1993) The effect of cyclic GMP and cyclic AMP on migration by electroporated human neutrophils. Eur J Pharmacol 246:157–161Google Scholar
  32. Elferink JGR, VanUffelen BE (1996) The role of cyclic nucleotides in neutrophil migration. Gen Pharmacol 27:387–393Google Scholar
  33. Filippov G, Bloch DB, Bloch KD (1997) Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. J Clin Invest 100:942–948Google Scholar
  34. Fisch TM, Prywes R, Simon MC, Roeder RG (1989) Multiple sequence elements in the c-fos promoter mediate induction by cAMP. Genes Dev 3:198–211Google Scholar
  35. Francis SH, Corbin JD (1994) Structure and function of cyclic nucleotide-dependent protein kinases. Annu Rev Physiol 56:237–272Google Scholar
  36. French PJ, Bijman J, Edixhoven M, Vaandrager AB, Scholte BJ, Lohmann SM, Nairn AC, DeJonge HR (1995) Isotype-specific activation of cystic fibrosis transmembrane conductance regulator-chloride channel by cGMP-dependent protein kinase II. J Biol Chem 270:26626–26631Google Scholar
  37. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA (1995) Definition of two angiogenic pathways by distinct alpha v integrins. Science 270:1500–1502Google Scholar
  38. Gambaryan S, Häusler C, Markert T, Pöhler D, Jarchau T, Walter U, Haase W, Kurtz A, Lohmann SM (1996) Expression of type II cGMP-dependent protein kinase in rat kidney is regulated by dehydration and correlated with renin gene expression. J Clin Invest 98:662–670Google Scholar
  39. Gambaryan S, Wagner C, Smolenski A, Walter U, Poller W, Haase W, Kurtz A, Lohmann SM (1998) Endogenous or overexpressed cGMP-dependent protein kinase inhibit cAMP-dependent renin release from rat isolated perfused kidney, microdissected glomeruli, and isolated juxtaglomerular cells. Proc Natl Acad Sci USA 95:9003–9008Google Scholar
  40. Garg UC, Hassid A (1989) Nitric oxide-generating vasodilators and 8-Bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774–1777Google Scholar
  41. Geiger J, Nolte C, Butt E, Sage SO, Walter U (1992) Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. Proc Natl Acad Sci USA 89:1031–1035Google Scholar
  42. Geiger J, Nolte C, Walter U (1994) Regulation of calcium mobilization and calcium entry in human platelets by cyclic nucleotide-elevating and endothelium-derived factors. Am J Physiol 267:C236–C244Google Scholar
  43. Gill GN, Holdy KE, Walton GM, Kanstein CB (1976) Purification and characterization of 3′,5′-cyclic GMP-dependent protein kinase. Proc Natl Acad Sci USA 73:3918–3922Google Scholar
  44. Glass DB, Cheng HC, Kemp BE, Walsh DA (1986) Differential and common recognition of the catalytic sites of the cGMP-dependent and cAMP-dependent protein kinases by inhibitory peptides derived from the heat-stable inhibitor protein. J Biol Chem 261:12166–12171Google Scholar
  45. Gong JH, Renz H, Sprenger H, Nain M, Gemsa D (1990) Enhancement of tumor necrosis factor-alpha gene expression by low doses of prostaglandin E2 and cyclic GMP. Immunobiology 182:44–55Google Scholar
  46. Gorlich D, Mattaj IW (1996) Nucleocytoplasmic transport. Science 271:1513–1518Google Scholar
  47. Gudi T, Huvar I, Meinecke M, Lohmann SM, Boss GR, Pilz RB (1996) Regulation of gene expression by cGMP-dependent protein kinase. Transactivation of the c-fos promoter. J Biol Chem 271:4597–4600Google Scholar
  48. Gudi T, Lohmann SM, Pilz RB (1997) Regulation of gene expression by cyclic GMP-dependent protein kinase requires nuclear translocation of the kinase:identification of a nuclear localization signal. Mol Cell Biol 17:5244–5254Google Scholar
  49. Haby C, Lisovoski F, Aunis D, Zwiller J (1994) Stimulation of the cyclic GMP pathway by NO induces expression of the immediate early genes c-fos and junB in PC12 cells. J Neurochem 62:496–501Google Scholar
  50. Hagiwara M, Brindle P, Harootunian A, Armstrong R, Rivier J, Vale W, Tsien R, Montminy MR (1993) Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol Cell Biol 13:4852–4859Google Scholar
  51. Hasegawa T, Takagi S, Nishimaki K, Morita K, Nakajima S (1992) Impairment of L-arginine metabolism in spontaneously hypertensive rats. Biochem Int 26:653–658Google Scholar
  52. Hofmann F, Dostmann W, Keilbach A, Landgraf W, Ruth P (1992) Structure and physiological role of cGMP-dependent protein kinase. Biochim Biophys Acta 1135:51–60Google Scholar
  53. Horstrup K, Jablonka B, Honig-Liedl P, Just M, Kochsiek K, Walter U (1994) Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition. Eur J Biochem 225:21–27Google Scholar
  54. Ignarro L, Murad F (1995) Nitric oxide. Biochemistry, molecular biology and therapeutic implications. Academic Press, San DiegoGoogle Scholar
  55. Ikeda M, Kohno M, Takeda T (1995) Inhibition by cardiac natriuretic peptides of rat vascular endothelial cell migration. Hypertension 26:401–405Google Scholar
  56. Inoue A, Hiruma Y, Hirose S, Yamaguchi A, Hagiwara H (1995) Reciprocal regulation by cyclic nucleotides of the differentiation of rat osteoblast-like cells and mineralization of nodules. Biochem Biophys Res Commun 215:1104–1110Google Scholar
  57. Inoue A, Hiruma Y, Hirose S, Yamaguchi A, Furuya M, Tanaka S, Hagiwara H (1996) Stimulation by C-type natriuretic peptide of the differentiation of clonal osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 221:703–707Google Scholar
  58. Itoh H, Pratt RE, Dzau VJ (1990) Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest 86:1690–1697Google Scholar
  59. Itoh H, Pratt RE, Ohno M, Dzau VJ (1992) Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells. Hypertension 19:758–761Google Scholar
  60. Jarchau T, Hausler C, Markert T, Pohler D, Vanderkerckhove J, De Jonge HR, Lohmann SM, Walter U (1994) Cloning, expression, and in situ localization of rat intestinal cGMP-dependent protein kinase II. Proc Natl Acad Sci USA 91:9426–9430Google Scholar
  61. Johnston HM, Morris BJ (1994) NMDA and nitric oxide increase microtubule-associated protein 2 gene expression in hippocampal granule cells. J Neurochem 63:379–382Google Scholar
  62. Kalderon D, Rubin G M (1989) cGMP-dependent protein kinase genes in Drosophila. J Biol Chem 264:10738–10748Google Scholar
  63. Kaupp UB (1995) Family of cyclic nucleotide gated ion channels. Curr Opin Neurobiol 5:434–442Google Scholar
  64. Kawada N, Kuroki T, Uoya M, Inoue M, Kobayashi K (1996) Smooth muscle alpha-actin expression in rat hepatic stellate cell is regulated by nitric oxide and cGMP production. Biochem Biophys Res Commun 229:238–242Google Scholar
  65. Kemp BE, Cheng H-C, Walsh DA (1988) Peptide inhibitors of cAMP-dependent protein kinases. Methods Enzymol 159:173–183Google Scholar
  66. Kim YM, Talanian RV, Billiar TR (1997) Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 272:31138–31148Google Scholar
  67. Koesling D, Bohme E, Schultz G (1991) Guanylyl cyclases, a growing family of signal-transducing enzymes. FASEB J 5:2785–2791Google Scholar
  68. Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Ueda M, Yoshikawa J (1997) Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells. Circ Res 81:585–590Google Scholar
  69. Kuo JF, Greengard P (1970) Cyclic nucleotide-dependent protein kinase VI. Isolation and partial purification of a protein kinase activated by guanosine 3′,5′-monophosphate. J Biol Chem 245:2493–2498Google Scholar
  70. Kuo JF, Davis CW, Tse J (1976) Depressed cardiac cyclic GMP-dependent protein kinase in spontaneously hypertensive rats and its further depression by guanethidine. Nature 261:335–336Google Scholar
  71. Kurose I, Kubes P, Wolf R, Anderson DC, Paulson J, Miyasaka M, Granger DN (1993) Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ Res 73:164–171Google Scholar
  72. Lau YT, Ma WC (1996) Nitric oxide inhibits migration of cultured endothelial cells. Biochem Biophys Res Commun 221:670–674Google Scholar
  73. Lee MR, Li L, Kitazawa T (1997) Cyclic GMP causes Ca2+ desensitization in vascular smooth muscle by activating the myosin light chain phosphatase. J Biol Chem 272:5063–5068Google Scholar
  74. Lincoln TM, Dills WL, Corbin JD (1977) Purification and subunit composition of guanosine 3′:5′-monophosphate-dependent protein kinase from bovine lung. J Biol Chem 252:4269–4275Google Scholar
  75. Lincoln TM, Komalavilas P, Boerth NJ, MacMillan-Crow LA, Cornwell TL (1995a) cGMP signaling through cAMP-and cGMP-dependent protein kinases. Adv Pharmacol 34:305–322Google Scholar
  76. Lincoln TM (1995b) Nitric oxide in the nervous system. Academic Press, San Diego 51 ppGoogle Scholar
  77. Lohmann SM, Vaandrager AB, Smolenski A, Walter U, DeJonge HR (1997) Distinct and specific functions of cGMP-dependent protein kinases. TIBS 22:307–312Google Scholar
  78. Loweth AC, Williams GT, Scarpello JH, Morgan NG (1997) Evidence for the involvement of cGMP and protein kinase G in nitric oxide-induced apoptosis in the pancreatic B-cell line, HIT-T15. FEBS Lett 400:285–288Google Scholar
  79. Markert T, Krenn V, Leebmann J, Walter U (1996) High expression of the focal adhesion-and microfilament-associated protein VASP in vascular smooth muscle and endothelial cells of the intact human vessel wall. Basic Res Cardiol 91:337–343Google Scholar
  80. Matsuoka H, Nakata M, Kohno K, Koga Y, Nomura G, Toshima H, Imaizumi T (1996) Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats. Hypertension 27:14–18Google Scholar
  81. McEver RP, Cummings RD (1997) Perspectives series:cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 100:485–491Google Scholar
  82. Mecham RP, Levy BD, Morris SL, Madaras JG, Wrenn DS (1985) Increased cyclic GMP levels lead to a stimulation of elastin production in ligament fibroblasts that is reversed by cyclic AMP. J Biol Chem 260:3255–3258Google Scholar
  83. Mönks D, Lange V, Silber RE, Markert T, Walter U, Nehls V (1998) Expression of cGMP-dependent protein kinase I and its substrate VASP in neointimal cells of the injured rat carotid artery. Eur J Clin Invest, 28:416–423Google Scholar
  84. Morita T, Mitsialis SA, Koike H, Liu Y, Kourembanas S (1997) Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 272:32804–32809Google Scholar
  85. Murphy-Ullrich JE, Pallero MA, Boerth N, Greenwood JA, Lincoln TM, Cornwell TL (1996) Cyclic GMP-dependent protein kinase is required for thrombospondin and tenascin mediated focal adhesion disassembly. J Cell Sci 109:2499–2508Google Scholar
  86. Niu XF, Smith CW, Kubes P (1994) Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 74:1133–1140Google Scholar
  87. Niu XF, Ibbotson G, Kubes P (1996) A balance between nitric oxide and oxidants regulates mast cell-dependent neutrophil-endothelial cell interactions. Circ Res 79:992–999Google Scholar
  88. Nolte C, Eigenthaler M, Schanzenbächer P, Walter U (1991) Endothelial cell-dependent phosphorylation of a platelet protein mediated by cAMP-and cGMP-elevating factors. J Biol Chem 266:14808–14812Google Scholar
  89. Orstavik S, Natarajan V, Tasken K, Jahnsen T, Sandberg M (1997) Characterization of the human gene coding for the type I alpha and type I beta cGMP-dependent protein kinase. Genomics 42:311–318Google Scholar
  90. Osborne KA, Robichon A, Burgess E, Butland S, Shaw RA, Coulthard A, Pereira HS, Greenspan RJ, Sokolowski MB (1996) Natural behavior polymorphism due to a cGMP-dependent protein kinase of Drosophila. Science 277:834–836Google Scholar
  91. Papapetropoulos A, Desai KM, Rudic RD, Mayer B, Zhang R, Ruiz-Torres MP, Garcia-Cardena G, Madri JA, Sessa WC (1997a) Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro. Am J Pathol 150:1835–1844Google Scholar
  92. Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC (1997b) Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100:3131–3139Google Scholar
  93. Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ, Ledda F, Ziche M (1998) Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium. J Biol Chem 273:4220–4226Google Scholar
  94. Peng HB, Libby P, Liao JK (1995) Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 270:14214–14219Google Scholar
  95. Perez-Albuerne ED, Schatteman G, Sanders LK, Nathans D (1993) Transcriptional regulatory elements downstream of the JunB gene. Proc Natl Acad Sci USA 90:11960–11964Google Scholar
  96. Peunova N, Enikolopov G (1993) Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells. Nature 364:450–453Google Scholar
  97. Pfeifer A, Nurnberg B, Kamm S, Uhde M, Schultz G, Ruth P, Hofmann F (1995) Cyclic GMP-dependent protein kinase blocks pertussis-toxin.sensitive hormone receptor signaling pathways in Chinese hamster ovary cells. J Biol Chem 270:9052–9059Google Scholar
  98. Pfeifer A, Aszodi A, Seidler U, Ruth P, Hofmann F, Fässler R (1996) Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II. Science 274:2082–2086Google Scholar
  99. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneiss C, Wang G-X, Korth M, Aszodi A, Andersson K-E, Krombach F, Mayerhofer A, Ruth P, Fässler R, Hofmann F (1998) Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J 17:3045–3051Google Scholar
  100. Pilz RB, Berjis M, Idriss SD, Scheele JS, Suhasini M, Gao L, Scheffler IE, Boss GR (1994) Isolation and characterization of HL-60 cells resistant to nitroprusside-induced differentiation. J Biol Chem 269:32155–32161Google Scholar
  101. Pilz RB, Suhasini M, Idriss S, Meinkoth JL, Boss GR (1995) Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J 9:552–558Google Scholar
  102. Pollman MJ, Yamada T, Horiuchi M, Gibbons GH (1996) Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ Res 79:748–756Google Scholar
  103. Pryzwansky KB, Wyatt TA, Nichols H, Lincoln TM (1990) Compartmentalization of cyclic GMP-dependent protein kinase in formyl-peptide stimulated neutrophils. Blood 76:612–618Google Scholar
  104. Pryzwansky KB, Kidao S, Wyatt TA, Reed W, Lincoln TM (1995a) Localization of cyclic GMP-dependent protein kinase in human mononuclear phagocytes. J Leukoc Biol 57:670–678Google Scholar
  105. Pryzwansky KB, Wyatt TA, Lincoln TM (1995b) Cyclic guanosine monophosphate-dependent protein kinase is targeted to intermediate filaments and phosphorylates vimentin in A23187-stimulated human neutrophils. Blood 85:222–230Google Scholar
  106. Radomski MW, Palmer RM, Moncada S (1987) The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 148:1482–1489Google Scholar
  107. Reinhard M, Jarchau T, Walter U (1998) VASP. In: Guidebook to the cytoskeletal and motor proteins (Eds. Kreis T, Vale R), Oxford University Press, in pressGoogle Scholar
  108. Rhoades KL, Golub SH, Economou JS (1992) The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines. J Biol Chem 267:22102–22107Google Scholar
  109. Ruth P, Wang GX, Boekhoff I, May B, Pfeifer A, Penner R, Korth M, Breer H, Hofmann F (1993) Transfected cGMP-dependent protein kinase suppresses calcium transients by inhibition of inositol 1,4,5-trisphosphate production. Proc Natl Acad Sci USA 90:2623–2627Google Scholar
  110. Rybalkin SD, Beavo J (1996) Multiplicity within cyclic nucleotide phosphodiesterases. Biochem Soc Trans 24:1005–1009Google Scholar
  111. Sandberg M, Natarajan V, Ronander I, Kalderon D, Walter U, Lohmann SM, Jahnsen T (1989) Molecular cloning and predicted full-length amino acid sequence of the type Iß isozyme of cGMP-dependent protein kinase from human placenta. Tissue distribution and developmental changes in rat. FEBS Lett 225:321–329.Google Scholar
  112. Sansom SC, Stockand JD, Hall D, Williams B (1997) Regulation of large calcium-activated potassium channels by protein phosphatase 2A. J Biol Chem 272:9902–9906Google Scholar
  113. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC (1996) Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 78:225–230Google Scholar
  114. Schmidt HHHW, Walter U (1994) NO at work. Cell 78, 919–925.Google Scholar
  115. Schwartz SM (1997) Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest 100:S87–S89Google Scholar
  116. Smolenski A, Burkhardt M, Eigenthaler M, Butt E, Gambaryan S, Lohmann SM, Walter U (1998) Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO/cGMP effects. Naunyn-Schmiedeberg's Arch Pharmacol 358:134–139Google Scholar
  117. Soff GA, Cornwell TL, Cundiff DL, Gately S, Lincoln TM (1997) Smooth muscle expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP. J Clin Invest 100:2580–2587Google Scholar
  118. Stockert RJ, Ren Q (1997) Cytoplasmic protein mRNA interaction mediates cGMP-modulated translational control of the asialoglycoprotein receptor. J Biol Chem 272:9161–9165Google Scholar
  119. Suda M, Ogawa Y, Tanaka K, Tamura N, Yasoda A, Takigawa T, Uehira M, Nishimoto H, Itoh H, Saito Y, Shiota K, Nakao K (1998) Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc Natl Acad Sci USA 95:2337–2342Google Scholar
  120. Sugimoto T, Haneda M, Togawa M, Isono M, Shikano T, Araki S, Nakagawa T, Kashiwagi A, Guan KL, Kikkawa R (1996) Atrial natriuretic peptide induces the expression of MKP-1, a mitogen-activated protein kinase phosphatase, in glomerular mesangial cells. J Biol Chem 271:544–547Google Scholar
  121. Suhasini M, Li H, Lohmann SM, Boss GR, Pilz RB (1998) cGMP-dependent protein kinase inhibits the ras/mitogen-activated protein kinase pathway. Mol Cell Biol, in pressGoogle Scholar
  122. Sundqvist T, Forslund T, Bengtsson T, Axelsson KL (1994) S-nitroso-N-acetylpenicillamine reduces leukocyte adhesion to type I collagen. Inflammation 18:625–631Google Scholar
  123. Takahashi M, Ikeda U, Masuyama J, Funayama H, Kano S, Shimada K (1996) Nitric oxide attenuates adhesion molecule expression in human endothelial cells. Cytokine 8:817–821Google Scholar
  124. Takio K, Wade RD, Smith SB, Krebs EG, Walsh KA, Titani K (1984) Guanosine cyclic 3′,5′-phosphate-dependent protein kinase, a chimeric protein homologous with two separate protein families. Biochemistry 23:4207–4218Google Scholar
  125. Tetsuka T, Daphna-Iken D, Miller BW, Guan Z, Baier LD, Morrison AR (1996) Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells. J Clin Invest 97:2051–2056Google Scholar
  126. Thiriet N, Esteve L, Aunis D, Zwiller J (1997) Immediate early gene induction by natriuretic peptides in PC12 phaeochromocytoma and C6 glioma cells. Neuroreport 8:399–402Google Scholar
  127. Tsao PS, Buitrago R, Chan JR, Cooke JP (1996) Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1. Circulation 94:1682–1689Google Scholar
  128. Uberall F, Werner-Felmayer G, Schubert C, Grunicke HH, Wachter H, Fuchs D (1994) Neopterin derivatives together with cyclic guanosine monophosphate induce c-fos gene expression. FEBS Lett 352:11–14Google Scholar
  129. Uhler M D (1993) Cloning and expression of a novel cyclic GMP-dependent protein kinase from mouse brain. J Biol Chem 268:13586–13591Google Scholar
  130. Vaandrager AB, DeJonge HR (1996) Signalling by cGMP-dependent protein kinases. Mol Cell Biochem 157:23–30Google Scholar
  131. Vaandrager AB, Tilly BC, Smolenski A, Schneider-Rasp S, Bot AGM, Edixhoven M, Scholte BJ, Jarchau T, Walter U, Lohmann SM, Poller WC, DeJonge HR (1997) cGMP-stimulation of cystic fibrosis transmembrane conductance regulator Cl channels co-expressed with cGMP-dependent protein kinase type II but not type Iß. J Biol Chem 272:4195–4200Google Scholar
  132. Vaandrager AB, Smolenski A, Tilly BC, Housmuller AB, Ehlert EME, Bot AGM, Edixhoven M, Boomaars WEM, Lohmann SM, DeJonge HR (1998) Membrane targeting of cGMP-dependent protein kinase is required for cystic fibrosis transmembrane conductance regulator Cl channel activation. Proc Natl Acad Sci USA 95:1466–1471Google Scholar
  133. Vemulapalli S, Chiu PJ, Kurowski S, Brown A, Hartman BD, Leach MW (1996) In vivo inhibition of platelet adhesion by a cGMP-mediated mechanism in balloon catheter injured rat carotid artery. Pharmacology 52:235–242Google Scholar
  134. Venturini CM, Weston LK, Kaplan JE (1992) Platelet cGMP, but not cAMP, inhibits thrombin-induced platelet adhesion to pulmonary vascular endothelium. Am J Physiol 263:H606–H612Google Scholar
  135. Vo NK, Gettemy JM, Coghlan VM (1998) Identification of cGMP-dependent protein kinase anchoring proteins (GKAPs). Biochem Biophys Res Commun 246:831–835Google Scholar
  136. Waldmann R, Walter U (1989) Cyclic nucleotide elevating vasodilators inhibit platelet aggregation at an early step of the activation cascade. Eur J Pharmacol 159:317–320Google Scholar
  137. Walter U (1984) Cyclic GMP-regulated enzymes and their possible physiological functions. Adv Cycl Nucl Prot Phosphor Res 17:249–258Google Scholar
  138. Walter U (1989) Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. Rev Physiol Biochem Pharmacol 113:41–88Google Scholar
  139. Wang GR, Zhu Y, Halushka PV, Lincoln TM, Mendelsohn ME (1998) Mechanism of platelet inhibition by nitric oxide:In vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci USA 95:4888–4893Google Scholar
  140. Wang S, Yan L, Wesley RA, Danner RL (1997) Nitric oxide increases tumor necrosis factor production in differentiated U937 cells by decreasing cyclic AMP. J Biol Chem 272:5959–5965Google Scholar
  141. Wedel A, Sulski G, Ziegler-Heitbrock HW (1996) CCAAT/enhancer binding protein is involved in the expression of the tumour necrosis factor gene in human monocytes. Cytokine 8:335–341Google Scholar
  142. Wedel BJ, Garbers DL (1997) New insights on the functions of the guanylyl cyclase receptors. FEBS Lett 410:29–33Google Scholar
  143. Wernet W, Flockerzi V, Hofmann F (1989) The cDNA of the two isoforms of bovine cGMP-dependent protein kinase. FEBS Lett 251:191–196Google Scholar
  144. Wu CC, Ko FN, Teng CM (1997) Inhibition of platelet adhesion to collagen by cGMP-elevating agents. Biochem Biophys Res Commun 231:412–416Google Scholar
  145. Wu X, Haystead TAJ, Nakamoto RK, Somlyo AV, Somlyo AP (1998) Acceleration of myosin light chain dephosphorylation and relaxation of smooth muscle by telokin. Synergism with cyclic nucleotide-activated kinase. J Biol Chem 273:11362–11369Google Scholar
  146. Wyatt TA, Lincoln TM, Pryzwansky KB (1991) Vimentin is transiently co-localized with and phosphorylated by cyclic GMP-dependent protein kinase in formyl-peptide-stimulated neutrophils. J Biol Chem 266:21274–21280Google Scholar
  147. Yamada KM and Geiger B (1997) Molecular interactions in cell adhesion complexes. Curr Opin Cell Biol 9:76–85Google Scholar
  148. Yoshida T, Hayashi M, Monkawa T, Saruta T (1996) Regulation of obese mRNA expression by hormonal factors in primary cultures of rat adipocytes. Eur J Endocrinol 135:619–625Google Scholar
  149. Yu SM, Hung LM, Lin CC (1997) cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. Circulation 95:1269–1277Google Scholar
  150. Zhou XB, Ruth P, Schlossmann J, Hofmann F, Korth M (1996) Protein phosphatase 2A is essential for the activation Ca2+-activated K+ currents by cGMP-dependent protein kinase in tracheal smooth muscle and Chinese hamster ovary cells. J Biol Chem 271:19760–19767Google Scholar
  151. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R (1997) Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99:2625–2634Google Scholar

Copyright information

© Springer-Verlag 1999

Authors and Affiliations

  • M. Eigenthaler
    • 1
  • S. M. Lohmann
    • 1
  • U. Walter
    • 1
  • R. B. Pilz
    • 1
    • 2
  1. 1.Institut für Klinische Biochemie und PathobiochemieMedizinische UniversitätsklinikWürzburgGermany
  2. 2.Department of MedicineUniversity of CaliforniaSan Diego, La JollaUSA

Personalised recommendations